# CYTK PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/CYTK
Company: Cytokinetics

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with CYTK.

## CYTK PDUFA Milestones

- 2025-12-19 — FDA Approval — FDA approved application. FDA recorded approval of MYQORZO on December 19, 2025. This list-only historical record is sourced from the official FDA applicatio...
  Company: Cytokinetics
  Source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219083
  Event detail: https://biopharmsignal.com/pdufa-calendar/CYTK/myqorzo-nda-219083-orig-1.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/december (December 2025)

## Related Pages

- Company page: https://biopharmsignal.com/company/CYTK
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the CYTK PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with CYTK, including decision dates, application stage, and summary details when available.
### Where can I find more context for CYTK?

Use the BioPharmSignal company page for CYTK to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.